Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Lipocine Inc. (LPCN) had Operating Cash Flow per Share of $-1.71 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.98M |
|
$-9.63M |
|
-- |
|
$1.98M |
|
$12.35M |
|
$-10.37M |
|
$0.74M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
$-10.37M |
|
$-10.50M |
|
5.45M |
|
5.71M |
|
$-1.77 |
|
$-1.77 |
|
| Balance Sheet Financials | |
$16.88M |
|
$0.10M |
|
$0.13M |
|
$17.01M |
|
$2.53M |
|
-- |
|
-- |
|
$2.53M |
|
$14.48M |
|
$14.48M |
|
$14.48M |
|
6.16M |
|
| Cash Flow Statement Financials | |
$-9.76M |
|
$5.89M |
|
$2.87M |
|
$6.21M |
|
$5.21M |
|
$-1.00M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-524.69% |
|
-524.69% |
|
-531.37% |
|
-487.05% |
|
-487.06% |
|
$-9.76M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
1.70 |
|
214.12 |
|
-66.50% |
|
-66.50% |
|
-56.61% |
|
-66.50% |
|
$2.35 |
|
$-1.71 |
|
|
Operating Cash Flow per Share |
$-1.71 |